These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 12188412)
1. Estrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial Hospital. Lertsanguansinchai P; Chottetanaprasith T; Chatamra K; Sampatanukul P; Wannakrairot P; Rojpornpradit P; Shotelersuk K; Lertbutsayanukul C; Boonjunwetwat D; Vajragupta L J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S193-202. PubMed ID: 12188412 [TBL] [Abstract][Full Text] [Related]
2. Expression of estrogen and progesterone receptors in human ductal invasive breast carcinoma not otherwise specified: is there any difference between premenopausal and postmenopausal women? Petricević J; Petković M; Jonjić N Acta Clin Croat; 2011 Jun; 50(2):169-75. PubMed ID: 22263379 [TBL] [Abstract][Full Text] [Related]
3. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228 [TBL] [Abstract][Full Text] [Related]
4. Breast carcinoma in women 35 years and younger: a pathological study. Fernandopulle SM; Cher-Siangang P; Tan PH Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742 [TBL] [Abstract][Full Text] [Related]
5. Angiogenesis and ER/PR status in primary breast cancer patients: an analysis of 158 needle core biopsies. Vameşu S Rom J Morphol Embryol; 2007; 48(1):25-31. PubMed ID: 17502947 [TBL] [Abstract][Full Text] [Related]
6. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand. Shahi KS; Bhandari G; Singh A J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374 [TBL] [Abstract][Full Text] [Related]
8. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma. Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P Breast J; 2005; 11(4):278-80. PubMed ID: 15982396 [TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer]. Mchedlishvili MIu; Gabunia UA; Makharoblidze ER; Burnadze KT; Piradashvili DZ Georgian Med News; 2005 Feb; (119):65-7. PubMed ID: 15834186 [TBL] [Abstract][Full Text] [Related]
10. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients. Aryandono T; Harijadi ; Ghozali A Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217 [TBL] [Abstract][Full Text] [Related]
11. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan. Sharif MA; Mamoon N; Mushtaq S; Khadim MT J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313 [TBL] [Abstract][Full Text] [Related]
12. [Relationship of oncogene C-erbB2 expression to ER, PR and PS2 in breast cancer and its prognostic significance]. Yang JQ; Chen L; Xing TY Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):334-6, 357. PubMed ID: 15181828 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer: steroid receptors and other prognostic indicators. Fatima S; Faridi N; Gill S J Coll Physicians Surg Pak; 2005 Apr; 15(4):230-3. PubMed ID: 15857597 [TBL] [Abstract][Full Text] [Related]
14. Tumor marker phenotype concordance in second primary breast cancer, California, 1999-2004. Brown M; Bauer K; Pare M Breast Cancer Res Treat; 2010 Feb; 120(1):217-27. PubMed ID: 19629680 [TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen value as a marker in breast cancer. Narita D; Cimpean AM; Anghel A; Raica M Neoplasma; 2006; 53(2):161-7. PubMed ID: 16575473 [TBL] [Abstract][Full Text] [Related]
16. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients. Ikpatt OF; Ndoma-Egba R Cent Afr J Med; 2003; 49(11-12):122-6. PubMed ID: 15301464 [TBL] [Abstract][Full Text] [Related]
17. Correlation of steroid receptors with histopathologic characteristics in breast carcinoma. Bhatavdekar JM; Trivedi SN; Shah NG; Karelia NH; Patel DD; Giri DD; Patel TB Neoplasma; 1988; 35(4):413-23. PubMed ID: 3185838 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of oestrogen and progesterone receptors, and c-erbB-2 in carcinoma of the breast in Trinidadian women. Rao AV; Mohammed WA; Ragoonanan C; Omo-Igbinomwanhia NE West Indian Med J; 2002 Mar; 51(1):4-9. PubMed ID: 12089875 [TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological characteristics and prognosis of patients with breast cancer over 65 years of age]. Gao JD; Zhang BN; Wang X; Wang J; Bi XF Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):83-6. PubMed ID: 19489267 [TBL] [Abstract][Full Text] [Related]
20. [Estradiol and progesterone receptors in loco-regional breast cancer. Clinical and prognostic correlations]. Bolla M; Chedin M; Chambaz E; Gabelle P Sem Hop; 1984 Jan; 60(2):91-6. PubMed ID: 6322331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]